Evidence map›Paper›PMID 39565448›Full record

ArticleMikrochimica acta2024

Functionalizing of magnetic nanoparticles as nano-architecture towards bioimaging and colorimetric recognition of MCF-7 cells: dual opto-sensing and fluorescence monitoring for early-stage diagnosis of breast cancer.

Hadi Gheybalizadeh, Abolghasem Jouyban, Mohammad Hasanzadeh, Jafar Ezzati Nazhad Dolatabadi, Payam Shahbazi-Derakhshi, Zahra Golsanamlu, Jafar Soleymani, Saeedeh Khadivi-Derakhshan

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hadi GheybalizadehLiver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abolghasem JouybanPharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammad HasanzadehPharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Jafar Ezzati Nazhad DolatabadiDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Payam Shahbazi-DerakhshiPharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Zahra GolsanamluPharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Jafar SoleymaniPharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. jsoleymanii@gmail.com.
Saeedeh Khadivi-DerakhshanDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.

Funding

National Institute for Medical Research Development 4021285
6 · The paper itself

Abstract

Considering the high incidence of breast cancer, a sensitive and specific approach is crucial for its early diagnosis and follow-up treatment. Folate receptors (FR), which are highly expressed on the epithelial tissue such as breast cancer cells (e.g., MCF-7), have been used in cancer diagnosis and bioimaging. This study presents an innovative colorimetric and fluorescence bioimaging platform towards MCF-7 using folic acid (FA)-conjugated iron-oxide magnetite silica-based nanocomposite (Fe

Indexed as

Breast NeoplasmsColorimetryFolic AcidSilicon DioxideBenzidinesCysteineEarly Detection of CancerFemaleFluorescent DyesHumansHydrogen PeroxideLimit of DetectionMagnetite NanoparticlesMCF-7 CellsNanocompositesOptical Imaging3,3',5,5'-tetramethylbenzidineamino-propyl-triethoxysilaneBenzidinesCysteineFluorescent DyesFolic AcidHydrogen PeroxideMagnetite NanoparticlesPlatinumPovidonePropylaminesSilanesSilicon DioxideBioimagingBreast cancer cellsColorimetric detectionMagnetite nanoparticlesNanozyme

Identifiers

PMID39565448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.